Moderna, Inc.
Explore Moderna, Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Moderna, Inc.
Explore Moderna, Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2021 Revenue
$17.7B
Source: Annual report / company filing
Moderna, Inc. reported $17.7B in revenue for fiscal year 2021. In 2022, revenue increased to $18.4B.
Spikevax made 2021 Moderna's breakout year, with the COVID-19 mRNA vaccine driving revenue to a peak of 17.7 billion dollars and lifting the company to unprecedented scale.
| Year | Revenue | YoY Change |
|---|---|---|
| FY2025 | $1.9B | -39.9% |
| FY2024 | $3.2B | -52.4% |
| FY2023 | $6.8B | -63.0% |
| FY2022 | $18.4B | +4.0% |
| FY2021 | $17.7B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.